BCAC

NASDAQ

Brookline Capital Acquisition Corp.

SectorIndustrialsIndustryConsumer Electronics/AppliancesIPO2021

News25/Ratings0

Brookline Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the life sciences industry. The company was founded in 2020 and is based in New York, New York.

News · 26 weeks20%

2025-10-262026-04-19

Mix290d

SEC Filings2(100%)

Latest news

25 items

59dSEC
Amendment: SEC Form S-1/A filed by Brookline Capital Acquisition Corp.
S-1/A - Brookline Capital Acquisition Corp II (0002102072) (Filer)
72dSEC
Amendment: SEC Form S-1/A filed by Brookline Capital Acquisition Corp.
S-1/A - Brookline Capital Acquisition Corp II (0002102072) (Filer)
1221dINSIDER
SEC Form 4: Wong Amy covered exercise/tax liability with 2,851 shares, decreasing direct ownership by 17% to 13,637 units
4 - Apexigen, Inc. (0001814140) (Issuer)
1221dINSIDER
SEC Form 4: Sarena Francis Willard covered exercise/tax liability with 6,916 shares, decreasing direct ownership by 17% to 33,084 units
4 - Apexigen, Inc. (0001814140) (Issuer)
1221dINSIDER
SEC Form 4: Hsu Frank J. covered exercise/tax liability with 4,323 shares, decreasing direct ownership by 17% to 20,677 units
4 - Apexigen, Inc. (0001814140) (Issuer)
1221dINSIDER
SEC Form 4: Duke William E. covered exercise/tax liability with 4,503 shares, decreasing direct ownership by 15% to 26,182 units
4 - Apexigen, Inc. (0001814140) (Issuer)
1221dINSIDER
SEC Form 4: Yang Xiaodong covered exercise/tax liability with 7,001 shares, decreasing direct ownership by 1% to 531,391 units
4 - Apexigen, Inc. (0001814140) (Issuer)
1256dSEC
SEC Form 10-Q filed by Brookline Capital Acquisition Corp.
10-Q - Apexigen, Inc. (0001814140) (Filer)
1256dSEC
Brookline Capital Acquisition Corp. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Other Events, Financial Statements and Exhibits
8-K - Apexigen, Inc. (0001814140) (Filer)
1290dINSIDER
SEC Form 4: Wong Amy was granted 16,488 shares
4 - Apexigen, Inc. (0001814140) (Issuer)
1290dINSIDER
SEC Form 4: Sarena Francis Willard was granted 40,000 shares
4 - Apexigen, Inc. (0001814140) (Issuer)
1290dINSIDER
SEC Form 4: Hsu Frank J. was granted 25,000 shares
4 - Apexigen, Inc. (0001814140) (Issuer)
1290dINSIDER
SEC Form 4: Duke William E. was granted 30,685 shares
4 - Apexigen, Inc. (0001814140) (Issuer)
1290dINSIDER
SEC Form 4: Yang Xiaodong was granted 40,488 shares, increasing direct ownership by 8% to 538,392 units
4 - Apexigen, Inc. (0001814140) (Issuer)
1295dSEC
SEC Form S-8 filed by Brookline Capital Acquisition Corp.
S-8 - Apexigen, Inc. (0001814140) (Filer)
1298dINSIDER
SEC Form 4 filed by Zabrowksi Dan
4 - Apexigen, Inc. (0001814140) (Issuer)
1298dINSIDER
SEC Form 4 filed by Wertheimer Samuel P
4 - Apexigen, Inc. (0001814140) (Issuer)
1298dINSIDER
SEC Form 4 filed by Smith Scott Andrew
4 - Apexigen, Inc. (0001814140) (Issuer)
1298dINSIDER
SEC Form 4 filed by Ringold Gordon
4 - Apexigen, Inc. (0001814140) (Issuer)
1298dINSIDER
SEC Form 4 filed by Chhabra Meenu
4 - Apexigen, Inc. (0001814140) (Issuer)
1298dINSIDER
SEC Form 4 filed by Dupont Jakob
4 - Apexigen, Inc. (0001814140) (Issuer)
1298dINSIDER
SEC Form 4 filed by Cross Herb
4 - Apexigen, Inc. (0001814140) (Issuer)
1319dSEC
SEC Form EFFECT filed by Brookline Capital Acquisition Corp.
EFFECT - Apexigen, Inc. (0001814140) (Filer)
1319dSEC
SEC Form EFFECT filed by Brookline Capital Acquisition Corp.
EFFECT - Apexigen, Inc. (0001814140) (Filer)
1322dSEC
SEC Form 424B3 filed by Brookline Capital Acquisition Corp.
424B3 - Apexigen, Inc. (0001814140) (Filer)